XNAS: RLMD
Relmada Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently...
Read More
3.75
-0.02
(-0.53%)
470.1K
XNAS Volume
XNAS 01 Oct, 2026 1:54 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Relmada Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..